{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T08:07:41Z","timestamp":1781251661780,"version":"3.54.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jid.2018.01.009","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T02:31:07Z","timestamp":1519007467000},"page":"1288-1292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Hidradenitis Suppurativa Is Associated with\u00a0Polycystic Ovary Syndrome: A\u00a0Population-Based Analysis in the United\u00a0States"],"prefix":"10.1016","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0886-6856","authenticated-orcid":false,"given":"Amit","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Neuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Strunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2018.01.009_bib1","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1001\/archinte.166.19.2081","article-title":"Prevalence and characteristics of the polycystic ovary syndrome in overweight and obese women","volume":"166","author":"Alvarez-Blasco","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jid.2018.01.009_bib2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1365-2133.1991.tb14162.x","article-title":"Androgen metabolism by isolated human axillary apocrine glands in hidradenitis suppurativa","volume":"125","author":"Barth","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2018.01.009_bib3","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1365-2133.1996.tb07942.x","article-title":"Endocrine factors in pre- and postmenopausal women with hidradenitis suppurativa","volume":"134","author":"Barth","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2018.01.009_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/DAD.0000000000000206","article-title":"Immunohistochemical analysis of steroid hormone receptors in hidradenitis suppurativa","volume":"37","author":"Buimer","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jid.2018.01.009_bib5","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12958-015-0115-z","article-title":"Identification of subjects with polycystic ovary syndrome using electronic health records","volume":"13","author":"Castro","year":"2015","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/j.jid.2018.01.009_bib6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/jc.2005-1666","article-title":"Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance","volume":"91","author":"Coviello","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jid.2018.01.009_bib7","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A\u00a0survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jid.2018.01.009_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/jc.2005-1329","article-title":"Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome","volume":"91","author":"Ehrmann","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jid.2018.01.009_bib9","unstructured":"Explorys Inc., Cleveland, Ohio. https:\/\/public.dhe.ibm.com\/common\/ssi\/ecm\/hp\/en\/hps03052usen\/HPS03052USEN.PDF (accessed 24 August 2017)."},{"key":"10.1016\/j.jid.2018.01.009_bib10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1186\/1471-2458-10-632","article-title":"Neighborhood socioeconomic status, Medicaid coverage and medical management of myocardial infarction: atherosclerosis risk in communities (ARIC) community surveillance","volume":"10","author":"Foraker","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jid.2018.01.009_bib11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1001\/jamadermatol.2017.0201","article-title":"Sex- and age-adjusted population analysis of prevalence estimates for hidradenitis suppurativa in the United States","volume":"153","author":"Garg","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2018.01.009_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jaad.2017.02.005","article-title":"Incidence of hidradenitis suppurativa in the United States: a sex- and age-adjusted population analysis","volume":"77","author":"Garg","year":"2017","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2018.01.009_bib13","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4158\/EP15748.DSC","article-title":"American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society disease state clinical review: guide to the best practices in the evaluation and treatment of polycystic ovary syndrome\u2014part 1","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jid.2018.01.009_bib14","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/bjs.1800751011","article-title":"Endocrine basis for the clinical presentation of hidradenitis suppurativa","volume":"75","author":"Harrison","year":"1988","journal-title":"Br J Surg"},{"key":"10.1016\/j.jid.2018.01.009_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2133.1988.tb03227.x","article-title":"The symptomatology of hidradenitis suppurativa in women","volume":"119","author":"Jemec","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2018.01.009_bib16","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMcp1014163","article-title":"Clinical practice. Hidradenitis suppurativa","volume":"366","author":"Jemec","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2018.01.009_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/09546630510031403","article-title":"Hidradenitis suppurativa treated with finasteride","volume":"16","author":"Joseph","year":"2005","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.jid.2018.01.009_bib18","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/j.1365-2133.2011.10224.x","article-title":"Hidradenitis suppurativa: a disease of the absent sebaceous gland? Sebaceous gland number and volume are significantly reduced in uninvolved hair follicles from patients with hidradenitis suppurativa","volume":"164","author":"Kamp","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2018.01.009_bib19","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1093\/humrep\/14.11.2720","article-title":"The prevalence of polycystic ovaries in women with infertility","volume":"14","author":"Kousta","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jid.2018.01.009_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2310\/7750.2007.00019","article-title":"Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy","volume":"11","author":"Kraft","year":"2007","journal-title":"J\u00a0Cutan Med Surg"},{"key":"10.1016\/j.jid.2018.01.009_bib21","first-page":"218","article-title":"Intracrinology and the skin","volume":"54","author":"Labrie","year":"2000","journal-title":"Horm Res"},{"key":"10.1016\/j.jid.2018.01.009_bib22","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/ajd.12362","article-title":"A\u00a0case series of 20 women with hidradenitis suppurativa treated with spironolactone","volume":"56","author":"Lee","year":"2015","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jid.2018.01.009_bib23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/humrep\/dep399","article-title":"The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria","volume":"25","author":"March","year":"2010","journal-title":"Hum Reprod"},{"key":"10.1016\/j.jid.2018.01.009_bib24","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1373\/49.4.624","article-title":"LOINC, a universal standard for identifying laboratory observations: a 5-year update","volume":"49","author":"McDonald","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.jid.2018.01.009_bib25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.det.2015.08.002","article-title":"Prevalence, risk factors, and comorbidities of hidradenitis suppurativa","volume":"34","author":"Miller","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jid.2018.01.009_bib26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2133.1986.tb05740.x","article-title":"A\u00a0double-blind crossover trial of cyproterone acetate in females with hidradenitis suppurativa","volume":"115","author":"Mortimer","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2018.01.009_bib27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/bmj.292.6515.245","article-title":"Mediation of hidradenitis suppurativa by androgens","volume":"292","author":"Mortimer","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.jid.2018.01.009_bib28","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/amiajnl-2011-000116","article-title":"Normalized names for\u00a0clinical drugs: RxNorm at 6 years","volume":"18","author":"Nelson","year":"2011","journal-title":"J\u00a0Am Med Inform Assoc"},{"key":"10.1016\/j.jid.2018.01.009_bib29","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1056\/NEJMct0707092","article-title":"Metformin for the treatment of the polycystic ovary syndrome","volume":"358","author":"Nestler","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jid.2018.01.009_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mce.2008.02.023","article-title":"(Neuro-)endocrinology of epithelial hair follicle stem cells","volume":"288","author":"Paus","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jid.2018.01.009_bib31","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.2337\/diacare.24.6.1050","article-title":"Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes","volume":"24","author":"Peppard","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jid.2018.01.009_bib32","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/jc.2006-2012","article-title":"Clinical review: identifying children at risk for polycystic ovary syndrome","volume":"92","author":"Rosenfield","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jid.2018.01.009_bib33","first-page":"711","article-title":"An exploration of the complex relationship of socioecologic factors in the treatment and outcomes of acute myocardial infarction in disadvantaged populations","volume":"36","author":"Shen","year":"2001","journal-title":"Health Serv Res"},{"key":"10.1016\/j.jid.2018.01.009_bib34","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","article-title":"Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis","volume":"71","author":"Shlyankevich","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2018.01.009_bib35","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jsbmb.2013.02.006","article-title":"Steroidogenesis in the skin: implications for local immune functions","volume":"137","author":"Slominski","year":"2013","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"key":"10.1016\/j.jid.2018.01.009_bib36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1159\/000468148","article-title":"Validation of a case-finding algorithm for hidradenitis suppurativa using administrative coding from a clinical database","volume":"233","author":"Strunk","year":"2017","journal-title":"Dermatology"},{"key":"10.1016\/j.jid.2018.01.009_bib37","unstructured":"U.S. National Library of Medicine Unified Medical Language System (UMLS): Systematized Nomenclature of Medicine\u2014Clinical Terms (SNOMED CT). http:\/\/www.nlm.nih.gov\/research\/umls\/Snomed\/snomed_main.html (accessed 2 August 2017)."},{"key":"10.1016\/j.jid.2018.01.009_bib38","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/j.1468-3083.2012.04668.x","article-title":"Metformin for the treatment of hidradenitis suppurativa: a little help along the way","volume":"27","author":"Verdolini","year":"2013","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2018.01.009_bib39","first-page":"230","article-title":"Human skin: an independent peripheral endocrine organ","volume":"54","author":"Zouboulis","year":"2000","journal-title":"Horm Res"},{"key":"10.1016\/j.jid.2018.01.009_bib40","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-2007-961807","article-title":"Sexual hormones in human skin","volume":"39","author":"Zouboulis","year":"2007","journal-title":"Horm Metab Res"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18300277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18300277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,21]],"date-time":"2019-06-21T08:53:53Z","timestamp":1561107233000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X18300277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0022202X18300277"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2018.01.009","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hidradenitis Suppurativa Is Associated with\u00a0Polycystic Ovary Syndrome: A\u00a0Population-Based Analysis in the United\u00a0States","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2018.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}